SK46699A3 - Method for producing an igm preparation for intravenous administration - Google Patents

Method for producing an igm preparation for intravenous administration Download PDF

Info

Publication number
SK46699A3
SK46699A3 SK466-99A SK46699A SK46699A3 SK 46699 A3 SK46699 A3 SK 46699A3 SK 46699 A SK46699 A SK 46699A SK 46699 A3 SK46699 A3 SK 46699A3
Authority
SK
Slovakia
Prior art keywords
igm
protein
proteinase
aqueous solution
solution
Prior art date
Application number
SK466-99A
Other languages
English (en)
Slovak (sk)
Inventor
Markus Rentsch
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Publication of SK46699A3 publication Critical patent/SK46699A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SK466-99A 1996-10-14 1997-10-14 Method for producing an igm preparation for intravenous administration SK46699A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810690A EP0835880A1 (de) 1996-10-14 1996-10-14 Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation
PCT/CH1997/000388 WO1998016558A1 (de) 1996-10-14 1997-10-14 VERFAHREN ZUR HERSTELLUNG EINES IgM-PRÄPARATES FÜR DIE INTRAVENÖSE APPLIKATION

Publications (1)

Publication Number Publication Date
SK46699A3 true SK46699A3 (en) 2000-06-12

Family

ID=8225725

Family Applications (1)

Application Number Title Priority Date Filing Date
SK466-99A SK46699A3 (en) 1996-10-14 1997-10-14 Method for producing an igm preparation for intravenous administration

Country Status (19)

Country Link
US (1) US6136312A (zh)
EP (1) EP0835880A1 (zh)
JP (1) JP2001504092A (zh)
KR (1) KR20000048826A (zh)
CN (1) CN1233258A (zh)
AU (1) AU725134B2 (zh)
BR (1) BR9712306A (zh)
CA (1) CA2266848A1 (zh)
CZ (1) CZ125599A3 (zh)
HU (1) HUP0001069A3 (zh)
ID (1) ID21364A (zh)
IL (1) IL129383A0 (zh)
NO (1) NO991733L (zh)
NZ (1) NZ334885A (zh)
PL (1) PL332774A1 (zh)
RU (1) RU2191032C2 (zh)
SI (1) SI9720063A (zh)
SK (1) SK46699A3 (zh)
WO (1) WO1998016558A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8142780B2 (en) * 1998-08-20 2012-03-27 Strox Biopharmaceuticals, Llc Anti-bacterial antibodies
AU2004256354B2 (en) * 2003-07-15 2011-07-07 Chugai Seiyaku Kabushiki Kaisha IgM production by transformed cells and methods for quantifying said IgM production
US7803914B2 (en) 2003-10-09 2010-09-28 Chugai Seiyaku Kabushiki Kaisha Methods for stabilizing protein solutions
WO2005035574A1 (ja) * 2003-10-09 2005-04-21 Chugai Seiyaku Kabushiki Kaisha IgM高濃度安定化溶液
EP1981540B1 (en) * 2006-01-30 2013-03-20 Grifols Therapeutics Inc. Method of treatment and prophylaxis of diseases related to amyloid deposition using igm
FR2899111B1 (fr) * 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament.
AU2009246510B2 (en) * 2008-05-12 2014-02-13 Strox Biopharmaceuticals, Llc Staphylococcus aureus-specific antibody preparations
CN101721633B (zh) * 2008-10-16 2011-12-21 岳道友 一种促进动物生长的中草药
GB201006753D0 (en) * 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
RU2470664C2 (ru) * 2010-08-23 2012-12-27 Андрей Германович Лютов Способ получения иммуноглобулина для внутривенного введения, обогащенного иммуноглобулином м, и препарат, полученный этим способом
CN106456763B (zh) 2014-06-03 2018-03-13 埃克斯生物科技公司 用于治疗和预防金黄色葡萄球菌感染的组合物和方法
CA3183021A1 (en) * 2020-07-10 2022-01-13 Myles Lindsay Method for obtaining a composition comprising human plasma-derived immunoglobulin m

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075193A (en) * 1976-11-26 1978-02-21 Parke, Davis & Company Process for producing intravenous immune globulin
DE2901822A1 (de) * 1979-01-18 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
IT1186766B (it) * 1985-11-08 1987-12-16 Sclavo Spa Metodo per la preparazione di immunoglobuline per uso endovenoso
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
DE3927112C1 (zh) * 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate

Also Published As

Publication number Publication date
AU725134B2 (en) 2000-10-05
JP2001504092A (ja) 2001-03-27
NO991733D0 (no) 1999-04-13
SI9720063A (sl) 1999-08-31
WO1998016558A1 (de) 1998-04-23
EP0835880A1 (de) 1998-04-15
HUP0001069A2 (hu) 2000-10-28
CZ125599A3 (cs) 1999-07-14
CN1233258A (zh) 1999-10-27
NZ334885A (en) 2000-09-29
NO991733L (no) 1999-06-11
AU4449597A (en) 1998-05-11
ID21364A (id) 1999-05-27
IL129383A0 (en) 2000-02-17
KR20000048826A (ko) 2000-07-25
PL332774A1 (en) 1999-10-11
RU2191032C2 (ru) 2002-10-20
US6136312A (en) 2000-10-24
BR9712306A (pt) 1999-08-31
HUP0001069A3 (en) 2000-12-28
CA2266848A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
EP0893450B1 (en) Chromatographic method for high yield purification and viral inactivation of IgG
EP2272870B1 (en) Process for manufacturing immunoglobulins for intravenous administration and other immunoglobulin-like products
US5164487A (en) Manufacturing intravenous tolerable immunoglobulin-g preparation
SK46699A3 (en) Method for producing an igm preparation for intravenous administration
ES2320919T3 (es) Proceso para separar el inhibidor de alfa-1-proteinasa de una pasta de fraccion cohn iv-1+iv-4.
PT703922E (pt) Processo de producao de concentrado de imunoglobulinas g
JP2644946B2 (ja) ＩｇＧ− モノクロナール抗体の精製方法及びその使用方法
EP1519944B1 (en) Processes for the preparation of fibrinogen
US4251510A (en) Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
US4272521A (en) Purified immune serum globulin
US5075425A (en) Process for the preparation of a pharmaceutical which contains igg, iga and igm and can be administered intravenously
US5041537A (en) Method of preparing a high-purity, virus safe, biologically active transferrin preparation
EP0148843B2 (en) A concentrate of the antihemophilic factor viii and a process for producing it
US4670544A (en) Process for the manufacture of the cold insoluble globulin and pharmaceutical preparation containing it
US5777081A (en) Process for producing an inter-alpha-trypsin inhibitor concentrate for therapeutic use and concentrate thus obtained
CA2185859C (en) Preparation of virally inactivated intravenously injectable immune serum globulin
CA2308904C (en) Process for the inactivation of viruses
JPH02180833A (ja) 蛋白質含有組成物の製造方法
US5378811A (en) Pure C3b inactivator and a process for producing said protein
MORIYA et al. Biochemical Studies on Kallikreins and Their Related Substances III. Preliminary Experiment of Studies on Human Plasma Kallikrein
RU1829938C (ru) Способ очистки гамма-глобулина дл внутривенного введени